标题
Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
作者
关键词
-
出版物
Science Bulletin
Volume 68, Issue 10, Pages 1069-1085
出版商
Elsevier BV
发表日期
2023-04-27
DOI
10.1016/j.scib.2023.04.028
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- E3 ligase ligand optimization of Clinical PROTACs
- (2023) Hanrui Jiang et al. Frontiers in Chemistry
- Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
- (2023) Yujeong Moon et al. Pharmaceutics
- PROTACs: Promising approach for anticancer therapy
- (2023) Simran Deep Kaur et al. CANCER LETTERS
- Advancing Strategies for Proteolysis-Targeting Chimera Design
- (2023) Minglei Li et al. Journal of Medicinal Chemistry
- Protein degraders enter the clinic — a new approach to cancer therapy
- (2023) Deborah Chirnomas et al. Nature Reviews Clinical Oncology
- Metal-free bioorthogonal click chemistry in cancer theranostics
- (2022) Dan Wu et al. CHEMICAL SOCIETY REVIEWS
- Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).
- (2022) Xin Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- Rational Design for Nitroreductase (NTR)-Responsive Proteolysis Targeting Chimeras (PROTACs) Selectively Targeting Tumor Tissues
- (2022) Shi Shi et al. JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Enzyme-Catalyzed Activation of Pro-PROTAC for Cell-Selective Protein Degradation
- (2022) Chunjing Liang et al. CCS Chemistry
- Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
- (2022) Sinan Ma et al. Acta Pharmaceutica Sinica B
- Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
- (2022) Jing Gao et al. Nature Communications
- Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors
- (2022) Chunrong Yang et al. Journal of the American Chemical Society
- Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
- (2021) Peter S. Dragovich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
- (2021) Peter S. Dragovich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant-selective degradation by BRAF-targeting PROTACs
- (2021) Shanique Alabi et al. Nature Communications
- Cancer Selective Target Degradation by Folate-Caged PROTACs
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted protein degraders crowd into the clinic
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
- (2021) Chi Zhang et al. Nature Communications
- Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
- (2021) Shipeng He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The PROTACtable genome
- (2021) Melanie Schneider et al. NATURE REVIEWS DRUG DISCOVERY
- Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy
- (2021) Kuikun Yang et al. ADVANCED MATERIALS
- Development of photocontrolled BRD4 PROTACs for tongue squamous cell carcinoma (TSCC)
- (2021) Zhenzhen Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The PROTAC gold rush
- (2021) Ken Garber NATURE BIOTECHNOLOGY
- Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
- (2021) Giulia Petroni et al. Nature Reviews Clinical Oncology
- A Fluorescent Probe for Rapid, High-Contrast Visualization of Folate-Receptor-Expressing Tumors In Vivo
- (2020) Koji Numasawa et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Proteolysis‐targeting chimeras in drug development: A safety perspective
- (2020) Kevin Moreau et al. BRITISH JOURNAL OF PHARMACOLOGY
- Optical Control of Small Molecule-Induced Protein Degradation
- (2020) Yuta Naro et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Stress- and ubiquitylation-dependent phase separation of the proteasome
- (2020) Sayaka Yasuda et al. NATURE
- Light-induced control of protein destruction by opto-PROTAC
- (2020) Jing Liu et al. Science Advances
- PHOTACs enable optical control of protein degradation
- (2020) Martin Reynders et al. Science Advances
- Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
- (2020) Marı́a Maneiro et al. ACS Chemical Biology
- Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
- (2020) Jing Gao et al. ACTA PHARMACOLOGICA SINICA
- First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).
- (2020) Daniel Peter Petrylak et al. JOURNAL OF CLINICAL ONCOLOGY
- Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown
- (2020) Yu-Hui Jin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting the folate receptor α in oncology
- (2020) Mariana Scaranti et al. Nature Reviews Clinical Oncology
- Hydrogen peroxide reactivity and specificity in thiol-based cell signalling
- (2020) Christine C. Winterbourn BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
- (2020) Tao Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Intact or in Pieces? A Look at How Clinically Approved, Biodegradable Block Co-Polymers Affect Blood Components
- (2020) Lauren Maghak et al. ACS Biomaterials-Science & Engineering
- Engineering Prodrug Nanomedicine for Cancer Immunotherapy
- (2020) Bin Yang et al. Advanced Science
- Quantitative Mapping of Glutathione within Intracranial Tumors through Interlocked MRI Signals of a Responsive Nanoprobe
- (2020) Peisen Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
- (2020) Katherine A. Donovan et al. CELL
- Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition
- (2020) Jing Gao et al. CHINESE CHEMICAL LETTERS
- Light-triggered release of photocaged therapeutics - Where are we now?
- (2019) Joana M. Silva et al. JOURNAL OF CONTROLLED RELEASE
- Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges
- (2019) Scott D. Edmondson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of targeted protein degradation therapeutics
- (2019) Philip P. Chamberlain et al. Nature Chemical Biology
- Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs
- (2019) Patrick Pfaff et al. ACS Central Science
- Sign Inversion in Photopharmacology: Incorporation of Cyclic Azobenzenes in Photoswitchable Potassium Channel Blockers and Openers
- (2019) Julie B. Trads et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Principles and applications of optogenetics in developmental biology
- (2019) Daniel Krueger et al. DEVELOPMENT
- Light-Induced Protein Degradation with Photocaged PROTACs
- (2019) Gang Xue et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Enzyme-Instructed Activation of Pro-protein Therapeutics In Vivo
- (2019) Jin Chang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Cellular quality control by the ubiquitin-proteasome system and autophagy
- (2019) Christian Pohl et al. SCIENCE
- Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality
- (2019) Philip P. Chamberlain et al. ACS Medicinal Chemistry Letters
- Glutathione-Responsive Self-Assembled Magnetic Gold Nanowreath for Enhanced Tumor Imaging and Imaging-Guided Photothermal Therapy
- (2018) Yijing Liu et al. ACS Nano
- Structure and Function of the 26S Proteasome
- (2018) Jared A.M. Bard et al. Annual Review of Biochemistry
- Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation
- (2018) Alexandru D. Buhimschi et al. BIOCHEMISTRY
- PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery
- (2018) Shanshan Gu et al. BIOESSAYS
- In Vivo Photopharmacology
- (2018) Katharina Hüll et al. CHEMICAL REVIEWS
- Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)
- (2018) Chengwei Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The expanding role of prodrugs in contemporary drug design and development
- (2018) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Principles of Ubiquitin-Dependent Signaling
- (2018) Eugene Oh et al. Annual Review of Cell and Developmental Biology
- Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
- (2018) Quinlan L. Sievers et al. SCIENCE
- How Big Is Too Big for Cell Permeability?
- (2017) Pär Matsson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
- (2017) Kwok-Ho Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
- (2017) Ian Churcher JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression
- (2017) Bing Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- (2017) Xiangpeng Dai et al. NATURE MEDICINE
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Waste disposal—An attractive strategy for cancer therapy
- (2017) Jemilat Salami et al. SCIENCE
- Emerging Targets in Photopharmacology
- (2016) Michael M. Lerch et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy
- (2016) Chao Liang et al. CHEMICAL SOCIETY REVIEWS
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
- (2016) Honorine Lebraud et al. ACS Central Science
- A Generic Platform for Cellular Screening Against Ubiquitin Ligases
- (2016) Timurs Maculins et al. Scientific Reports
- Deoxynyboquinones as NQO1-Activated Cancer Therapeutics
- (2015) Elizabeth I. Parkinson et al. ACCOUNTS OF CHEMICAL RESEARCH
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Hypoxia and hypoxia inducible factors in tumor metabolism
- (2015) Wen Zeng et al. CANCER LETTERS
- Nitroreductase-triggered activation of a novel caged fluorescent probe obtained from methylene blue
- (2015) Jungeun Bae et al. CHEMICAL COMMUNICATIONS
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- (2015) Jing Lu et al. CHEMISTRY & BIOLOGY
- Optogenetics
- (2015) Jens Duebel et al. CURRENT OPINION IN OPHTHALMOLOGY
- Prime time for PROTACs
- (2015) Raymond J Deshaies Nature Chemical Biology
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Optogenetics: 10 years of microbial opsins in neuroscience
- (2015) Karl Deisseroth NATURE NEUROSCIENCE
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- ortho-Fluoroazobenzenes: Visible Light Switches with Very Long-LivedZIsomers
- (2014) Christopher Knie et al. CHEMISTRY-A EUROPEAN JOURNAL
- Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer
- (2014) John M. Lambert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- Targeting Protein-Protein Interaction by Small Molecules
- (2013) Lingyan Jin et al. Annual Review of Pharmacology and Toxicology
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery
- (2013) Zhigang Yang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Catalase Abrogates -Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers
- (2013) E. A. Bey et al. MOLECULAR CANCER THERAPEUTICS
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α
- (2012) Dennis L. Buckley et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bioorthogonal Copper-Free Click Chemistry In Vivo for Tumor-Targeted Delivery of Nanoparticles
- (2012) Heebeom Koo et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
- (2012) Petr Klán et al. CHEMICAL REVIEWS
- o-Fluoroazobenzenes as Readily Synthesized Photoswitches Offering Nearly Quantitative Two-Way Isomerization with Visible Light
- (2012) David Bléger et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
- (2012) Dennis L. Buckley et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Development and Application of Optogenetics
- (2011) Lief Fenno et al. Annual Review of Neuroscience
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer
- (2011) Tracy R. Daniels et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The secret life of kinases: functions beyond catalysis
- (2011) Jens Rauch et al. Cell Communication and Signaling
- Wavelength-Selective Caged Surfaces: How Many Functional Levels Are Possible?
- (2011) Verónica San Miguel et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Targeting the Undruggable Proteome: The Small Molecules of My Dreams
- (2010) Craig M. Crews CHEMISTRY & BIOLOGY
- Vitamin B12in drug delivery: breaking through the barriers to a B12bioconjugate pharmaceutical
- (2010) Susan M Clardy et al. Expert Opinion on Drug Delivery
- Impact of linker length on the activity of PROTACs
- (2010) Kedra Cyrus et al. Molecular BioSystems
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase
- (2010) Mariam Aghajan et al. NATURE BIOTECHNOLOGY
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- The 26 S Proteasome: From Basic Mechanisms to Drug Targeting
- (2009) Ami Navon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Highly Efficient ReversibleZ−EPhotoisomerization of a Bridged Azobenzene with Visible Light through Resolved S1(nπ*) Absorption Bands
- (2009) Ron Siewertsen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
- (2008) Ashley R. Schneekloth et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Diversity of degradation signals in the ubiquitin–proteasome system
- (2008) Tommer Ravid et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started